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Abstract
Previous events evidence that sudden cardiac death (SCD) in athletes is still a reality and it keeps challenging cardi-
ologists. Considering the importance of SCD in athletes and the requisite for an update of this matter, we endea-
vored to describe SCD in athletes. The Medline (via PubMed) and SciELO databases were searched using the
subject keywords “sudden death, athletes and mortality”. The incidence of SCD is expected at one case for each
200,000 young athletes per year. Overall it is resulted of complex dealings of factors such as arrhythmogenic sub-
strate, regulator and triggers factors. In great part of deaths caused by heart disease in athletes younger than 35
years old investigations evidence cardiac congenital abnormalities. Athletes above 35 years old possibly die due to
impairments of coronary heart disease, frequently caused by atherosclerosis. Myocardial ischemia and myocardial
infarction are responsible for the most cases of SCD above this age (80%). Pre-participatory athletes’ evaluation
helps to recognize situations that may put the athlete’s life in risk including cardiovascular diseases. In summary,
cardiologic examinations of athletes’ pre-competition routine is an important way to minimize the risk of SCD.
Background
Athlete is defined as who participates in individual or
collective sports (any age) as well as training programs
of systematic and regular competitions [1-7].
Recent events in all parts of the world show that sud-
den cardiac death (SCD) of athletes is still a reality and it
continues to challenge experts in cardiology which works
with athletes [8-13]. SCD is defined by the World Health
Organization (WHO) as that condition which occurs
within the first 24 hours after the symptoms onset. How-
ever, several experts decrease this time and describe it as
an unexpected death, marked by abrupt loss of con-
sciousness in an individual within the first hour after
symptoms onset with or without heart disease [14].
SCD in athletes is rare (1:50,000 - 1:100,000 annually),
however, it is still 2-4 times more often when compared
to non athletes. Several mechanisms are proposed: myo-
cardial ischemia, repolarization due to potassium chan-
nel downregulation and it may also be explained by the
presence of multiple factors such as cardiac hypertrophy
(athlete’s heart) and/or hypertrophic cardiomyopathy,
increased sympathetic tone, genetic defects, drugs, dop-
ing agents or food ingredients. These factors together
m a yi n c r e a s et h er e p o l a r i z a t i o nh o m o g e n e i t yw h i c h
sometimes leads to risk of arrhythmias and SCD [15].
In not selected population the incidence of SCD is
0.001-0.002% per year. Nevertheless, in absolute value it
generates a significantly higher number. In selected
populations such as athletes the absolute value of deaths
decreased but the relative risk increases [15].
In Brazil and in the rest of the Latin American conti-
nent, the only statistic of SCD tracked over the years is
from the Institute of Cardiology Dante Pazzanese. More
than 25 years they have monitored SCD in athletes. The
statistics of this institution shows that in children and
adolescents mild abnormalities risks ranged from 17.7 to
21.0% while in active amateur athletes and in profes-
sionals younger than 35 years old it was 8.2%, this only
for cardiac factors. The results of the Italian Olympic
Committee regarding removal of athletes for heart dis-
ease were only 3% [16].
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any medium, provided the original work is properly cited.We believe that cardiologic evaluation of athletes’ pre-
competition routine is the only way to minimize the risk
of SCD in this selected population. In view of the
importance of SCD in athletes and the necessity for
an update of this issue, we aimed to describe SCD in
athletes through a systematic review.
Method
The Medline (via PubMed) and SciELO databases were
searched using the subject keywords “sudden death, ath-
letes and mortality”.W ea l s ou s e dt h e“related articles”
function on PubMed and SciELO with the references of
the studies. Publications were included in our review if
their titles or abstracts were available in English or Por-
tuguese and described SCD in athletes. The review was
completed on June 2010. Publications were excluded if
the treatment was limited to a particular technique.
Each publication was reviewed in order to identify the
author(s), study period and data source.
Results
In the review which we made in the mentioned data-
bases we found a total of 694 manuscripts. We excluded
investigations where the management was limited to a
particular method.
We summarized the main studies in Table 1, which
briefly describes important studies regarding SCD in
athletes.
Discussion
Epidemiology
The prevalence of SCD is estimated in one case for each
200,000 young athletes [17-19]. On the other hand, the
occurrence of SCD associated to training and competi-
tions for athletes is increased by 2.8 times compared to
the average relative risk of non-competitive practitioners
[20], hence giving rise to the following question: Does
sports activity causes sudden death in young people?
The most common cause of sudden death is cardio-
vascular origin according to the literature, with inci-
dence and nature of the subject areas. For example, the
family hypertrophic cardiomyopathy is more common in
the U.S., while right ventricular arrhythmogenic dyspla-
s i ah a v eag r e a t e re f f e c ti nt h er e g i o no fV e n e t oi nI t a l y
[15]. In Brazil, SCD was more frequent in soccer and
basketball. The occurrence of benign or potentially
malignant heart diseases cataloged over more than
30 years of evaluations of athletes ranging from adoles-
cents to elderly veterans in various sporting modalities
at Instituto Dante Pazzanese de Cardiologia, of children
younger than 14 years old at social clubs in São Paulo,
and of boys up to 18 years old who needed a “medical
examination” to enable them to train professional soccer
in São Paulo’s major league clubs [16].
From 1966 to 2004 it was reported 1,101 cases of sud-
den death in athletes younger than 35 years, 90% were due
to cardiovascular diseases, 50% presented anatomic conge-
nital cardiac diseases and cardiomyopathies, 10% pre-
sented early coronary atherosclerotic disease, 40%
occurred in athletes younger than 18 years and 33% below
16 years old, the ratio of female/male was 1/9. SCD was
reported for almost all sports, the majority involved soccer
(30%), basketball (25%) and runners (15%) [21].
Sadaniantz and Thompson [22] demonstrated that the
relative risk for sudden death increases during exercise,
although the absolute risk remains low. It is also
demonstrated that individuals who practice physical
activity less often present higher risk for sudden death
compared to those who practice exercise regularly
[23-27].
Table 1 Summary of the main clinical studies regarding SCD in athletes
Author and year Main findings
Germann et al, 2005
[2].
Most etiologies of SCD in athletes result in the same final common denominator (cardiac arrest) on presentation to an
emergency physician. There are certain historic, physical examination, and electrocardiographic features of many of these
disease processes that emergency physicians should have a working knowledge of to try to identify them before they result
in SCD.
Corrado et al, 2006
[3].
The incidence of SCD in young competitive athletes has substantially declined in the Veneto region of Italy since the
introduction of a nationwide systematic screening. Mortality reduction was predominantly due to a lower incidence of sudden
death from cardiomyopathies that paralleled the increasing identification of athletes with cardiomyopathies at preparticipation
screening.
Corrado et al, 2003
[15].
Sports activity in adolescents and young adults was associated with an increased risk of SCD, both in males and females.
Sports was not a cause of the enhanced mortality, but it triggered SCD in those athletes who were affected by cardiovascular
conditions predisposing to life-threatening ventricular arrhythmias during physical exercise
Maron et al, 1986
[46].
In most young competitive athletes (less than 35 years of age) sudden death is due to congenital cardiovascular disease.
Hypertrophic cardiomyopathy appears to be the most common cause of such deaths (about half of the sudden deaths in
young athletes). Other cardiovascular abnormalities that appear to be less frequent but important causes of sudden death in
young athletes include congenital coronary artery anomalies, ruptured aorta (due to cystic medial necrosis), idiopathic left
ventricular hypertrophy and coronary artery atherosclerosis. Diseases that appear to be very uncommon causes of sudden
death include myocarditis, mitral valve prolapse, aortic valve stenosis and sarcoidosis.
SCD: Sudden Cardiac Deaths.
Ferreira et al. Sports Medicine, Arthroscopy, Rehabilitation, Therapy & Technology 2010, 2:19
http://www.smarttjournal.com/content/2/1/19
Page 2 of 6Jeresaty [28] and Sadaniatz et al [22] estimated that
t h ep r e v a l e n c eo fm i t r a lv a l v ep r o l a p s ew a s6t o1 7 % .
These authors reported that 3% of sudden deaths related
to exercise are due to this dysfunction. If we consider
this prevalence, the risk of sudden death caused by
mitral valve prolapse is extremely low. If there are cases
of syncope, chest pain, disabling, complex ventricular
arrhythmias, cardiomegaly caused by moderate mitral
valve regurgitation or sudden death in the family the
exercise practice should be appropriately evaluated
[22,28].
When we investigate the causes of sudden death in
soccer players, we may describe two groups: The first
includes congenital cardiac abnormalities (mainly
obstructive hypertrophic cardiomyopathy and anoma-
lous origin of coronary arteries), and the second due to
coronary artery disease. In the both groups it is
observed fatal arrhythmias (SCD).
Pathophysiology
Several electrophysiological mechanisms may be respon-
sible for SCD, however, in general it is resulted of com-
plex interaction of factors such as arrhythmogenic
substrate, regulator and triggers factors: arrhythmogenic
substrate: it may be represented by a fibrotic or infiltra-
tive myocardial process, myocardial necrosis, ventricular
aneurysm, myocardial hypertrophy, myocardial inflam-
mation and electrocellular changes; regulator factors:
autonomic nervous system, renin-angiotensin system,
hydro-electrolyte disturbances, hypoxia, drug action,
hemodynamic factors, ischemia and blood pH and; trig-
ger factors: extra-systole and abrupt increases of heart
rate [15].
The arrhythmogenic substrates alone do not produce
fatal arrhythmia. It is necessary trigger factors acting on
it in a favorable context for the sustenance of the
arrhythmia - modifying factors [20]. Over 90% of deaths
among young athletes occur during training or competi-
tion [21,29,30]. It could support the fact that in the pre-
sence of certain diseases the physical exhaustion is the
trigger of lethal arrhythmias and sudden death in sport
area [20].
In general, the most common triggers for sudden
death are excessive physical effort, stress and the transi-
tion period from sleep to wakefulness on the first hours
of the morning. In these situations there is a peak of
sympathetic activity which promotes sudden increase of
myocardial demand and/or changes in vasomotor tone
of coronary arteries. These conditions may lead to rup-
ture of a plaque with subsequent thrombus formation,
leading to myocardial ischemia which may be mani-
fested as unstable angina, myocardial infarction or its
complications [31]. Abrupt obstructions of blood flow to
the heart may also result in arrhythmias and SCD. A
sudden obstruction of the mitral valve by myxoma, aor-
tic stenosis or obstruction of the left ventricle outflow
by septal hypertrophy may provide a fatal event in an
abrupt and unexpected way [31].
Although a rare event, sudden death in athletes gener-
ates great social and emotional impact throughout
society, especially when the victim is a young athlete, it
arises questions from the midia: Would be the sport
detrimental to health? Sudden death could be
prevented?
There is evidence that sports, including soccer, are
healthy to body and mind, except for a small group of
practitioners who have undiagnosed heart disease and
which it would not be recommended. However, at least
one of them could be prevented through pre-participa-
tory evaluations recommended to all practitioners of
physical activities in order to identify their conditions
that would lead to the final event [32].
In all types of sports it has been considered older ages
in which the athletes are classified as “masters”.T h e s e
ages are apparently arbitrary and vary according to the
sports. For instance, in water polo the age is 25 years
old and in bowling it is 50 years old. In soccer the age
is 35 years old and it is not reported in the literature
the objective criteria regarding these ages’ limits. Simi-
larly, the national and international publications follow
this categorization and in the world all these ages are
referred to as watershed between young athletes and
“masters” [32].
Cardiovascular causes of sudden death in athletes
younger than 35 years old
For the vast majority of deaths caused by cardiovascular
disease in athletes younger than 35 years old the litera-
ture relate congenital abnormalities of the heart, i.e., dis-
eases at birth. Among them the most commons are:
hypertrophic cardiomyopathy (36%), coronary artery
anomalies (19%) and increased ventricular mass (10%).
The remaining percentage is caused by other diseases
such as right ventricular arrhythmogenic dysplasia, Mar-
fan syndrome, the long QT syndrome, Brugada syn-
drome and catecholaminergic familiar tachycardia
[33,34]. Unfortunately, effective detection of these dis-
eases which may cause morbidity and sudden death in
athletes is very low; it was reported combined preva-
lence of 0.2% [33,34].
1. Congenital cardiac anomalies
A large number of congenital cardiac anomalies may be
found and listed as a cause of SCD during exercise;
however, the most prevalent according to literature
references are anomalous origin of left coronary artery
from pulmonary artery and hypertrophic cardiomyopa-
thy [34].
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artery trunk
It represents 0.25-0.5% or 4 per 1000 of all congenital
heart disease [35], it occurs in 0.2-1.2% of the popula-
tion and causes 12% of sudden deaths related to sports
(and 1.2% of deaths not related to sports) [36]. Among
all patients with anomalous origin of coronary arteries
only 10% reach adulthood. The diagnosis is usually
made post-death because most patients are asympto-
matic and the aggressive surgical treatment is indicated
due to the higher risk of SCD [37].
This pathological condition is not the only coronary
anomaly that causes SCD. In fact, this entity is rather
uncommon in adult population. The clinical and patho-
logical profile may be divided into child and adult [36].
The child type is observed in the absence of collateral
circulation, which explains the poor prognosis of
patients without intervention and the pattern of myocar-
dial infarction on electrocardiogram. It must cause in
infants by unexplained cardiomegaly [38], suggesting
that it is the responsibility of myocardial infarction,
heart failure and possibly death during early childhood
period [39]. The adult type is characterized by the
absence of early symptoms. In this case the collateral
circulation is present in a satisfactory manner and the
electrocardiogram is not significantly changed or even
normal. In this context coronary heart disease usually
manifests during effort which explains the sudden
deaths of young athletes [36].
The electrocardiogram (ECG) contributes to the most
of clinical diagnosis achievement, especially in sympto-
matic infants. In children and adults the electrocardio-
gram may be normal or almost normal [40], however,
two elements characterize the ECG of this entity: Stan-
dard of myocardial infarction, present in cases where
the collateral circulation of the right coronary artery is
insufficient (90% cases), more common in infants and;
Left ventricular hypertrophy standard as a consequence
of replication of myocytes conditioned by chronic
hypoxia. It is more frequently observed in adults.
1.2. Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy may be defined as myo-
cardial involvement without definitive etiology, charac-
t e r i z e db yl e f tv e n t r i c l eh y pertrophy (rarely right
ventricle), with myofibrillar disorder, increased left ven-
tricular ejection fraction and decreased cardiac output,
which depends on the functional impairment degree
[41-47]. The outflow tract obstruction may exist or not.
In this form of cardiomyopathy situations which present
increased ventricular mass caused by hypertension, aor-
tic stenosis or other defined causes are not included.
According to the anatomical characteristics of hyper-
trophic cardiomyopathy it may be symmetrical or
asymmetrical, in the case of SCD: asymmetric septal,
ventricular mean, septal apical, posteroseptal or rarely of
right ventricle [48].
The asymmetric septal hypertrophic cardiomyopathy is
the most prevalent and may occur in non-obstructive or
obstructive outflow of the left ventricle and it is revealed
at rest or with stress. Hemodynamically, it is noted pres-
sure gradient between the left ventricle and the aorta,
resulted from septal hypertrophy, which avoids the flow
through the left ventricle outflow. Due to the Venturi
effect, during ventricular systole the anterior leaflet of
the mitral valve come close to the interventricular sep-
tum (MSA) and anguishes the left ventricle outflow.
The mitral valve becomes incompetent allowing blood
reflux into the left atrial cavity due to the lacinia move-
ment. Regardless of the obstruction, there is hipodiastole
by impaired ventricular relaxation, which contributes to
cardiac output decrease [48].
It is estimated that cardiomyopathy may affect
between 0.001 and 0.2% of the population [49]. On the
other hand, the occasional finding of some septal hyper-
trophy degree during echocardiography was estimated at
approximately 0.5% [50]. It seems unanimous that
hypertrophic cardiomyopathy is the leading cause of
SCD related to exercises in athletes younger than
30 years old [51,52] which would be responsible for
around half of deaths and often appearing as first and
only manifestation of the disease. In some cases hyper-
trophy may be so important that septal thickness may
reach 30 mm. This degree of hypertrophy possibly lead
to left ventricular filling decrease and is able to produce
severe hemodynamic changes in the left ventricle out-
flow, which may cause ischemia and potentially fatal
arrhythmias [51].
Considering that septal hypertrophy may be totally
asymptomatic, this disease may be not diagnosed. A
detailed investigation in family history is of great value,
since this disease has a pattern distribution of dominant
autosomal genetic [53] in at least half of the cases, while
the gene is located on chromosomes 1, 11, 14 or 15 [54]
with predominance in males compared to females.
Albeit the relationship between hypertrophy degree and
symptoms magnitude is usually present, it is not always
observed, since some patients have a significant degree
of hypertrophy without any symptoms to report and the
reverse situation also exists. However, the risk of sudden
death is directly proportional to the left ventricular
hypertrophy degree, and the annual incidence of sudden
death is 0 to 1000 individuals with left ventricular thick-
ness lower than 15 mm and 18.2 for 1000 patients with
septal thickness equal or higher than 30 mm [55].
The natural history of hypertrophic cardiomyopathy
leads to heart failure and/or sudden death. It is difficult
to evaluate the prognosis of this disease because studies
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centers. Some manifestations are held for most of the
authors as worse prognosis: early diagnosis (particularly
children); large ventricular thickness, family history of
sudden death, personal history of resuscitated sudden
death, sustained (or not) ventricular tachycardia and
exercise-induced hypotension [53-55].
Causes of sudden death in athletes older than 35 years old
According to the literature, athletes older than 35 years
old may die due to complications of coronary heart dis-
ease often caused by atherosclerosis. Myocardial ische-
mia and myocardial infarction are responsible for most
of SCD above this age (80%) [51,56-60].
Concluding Remarks
This review does not allow us to surely identify the pre-
ference causes of SCD in athletes. Although this etiology
tends to prevail in older subjects, it seems that in com-
petitive sports there is insufficient evidence regarding
this matter. Acceptance of this premise may reduce the
preventive approach to SCD just aiming to exclude con-
genital heart in young and just deal with coronary risk
factors in the elderly, considering as secondary level the
prevention of other possible etiologies for the athletes,
including masters in football. The qualification by age
implies that as a result of age the athletes would present
limitations that would hamper their performance. More-
over, ages above 35 years old puts a real stigma in these
athletes, thus, compromising physical performance,
beyond the psychological involvement resulting on SCD
risk.
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